November 06, 2019 Aprea Therapeutics to Present Data from U.S. Phase 1b/2 MDS/AML Trial and French Phase 1b/2 MDS/AML Trial at 61st American Society of Hematology Annual Meeting
November 06, 2019 Oncopeptides to Highlight Data from Melflufen Clinical Program in Multiple Myeloma and AL Amyloidosis in Six Presentations at ASH Annual Meeting 2019
November 05, 2019 Strongbridge Biopharma plc Announces CEO Transition Plan and Provides Preliminary Third Quarter 2019 Financial Results and Corporate Updates
October 30, 2019 BONESUPPORT HOLDING AB (publ) – Q3 2019 Interim Report – invitation to conference call and webcast
October 29, 2019 Strongbridge Biopharma plc to Host Third Quarter 2019 Financial Results Conference Call on November 7, 2019
October 29, 2019 Targovax ASA: Invitation to presentation of Targovax’s third quarter 2019 results, Thursday 7 November